The authors reply

Affiliations

¹ Division of Kidney Diseases and Hypertension, Hofstra North Shore-LIJ School of Medicine, Great Neck, New York, USA.
² Division of Nephrology, Columbia University Medical Center, New York, New York, USA.

Free article

Comment

Kenar D Jhaveri et al. Kidney Int. 2014 Jan.

Free article

. 2014 Jan;85(1):214.

doi: 10.1038/ki.2013.411.

¹ Division of Kidney Diseases and Hypertension, Hofstra North Shore-LIJ School of Medicine, Great Neck, New York, USA.
² Division of Nephrology, Columbia University Medical Center, New York, New York, USA.

No abstract available

Comment on

Glomerular diseases seen with cancer and chemotherapy: a narrative review.
Jhaveri KD, Shah HH, Calderon K, Campenot ES, Radhakrishnan J. Jhaveri KD, et al. Kidney Int. 2013 Jul;84(1):34-44. doi: 10.1038/ki.2012.484. Epub 2013 Jan 30. Kidney Int. 2013. PMID: 23364518 Review.
Interferon-α-induced thrombotic microangiopathy in patients with chronic myelogenous leukemia.
Demoulin N, Jadoul M. Demoulin N, et al. Kidney Int. 2014 Jan;85(1):213-4. doi: 10.1038/ki.2013.409. Kidney Int. 2014. PMID: 24380910 No abstract available.
Pegylated liposomal doxorubicin and renal thrombotic microangiopathy: an under-recognized complication of prolonged treatment for ovarian cancer.
Shavit L, Lifschitz MD, Gabizon A, Kwa M, Muggia F, Slotki I. Shavit L, et al. Kidney Int. 2014 Jan;85(1):213. doi: 10.1038/ki.2013.408. Kidney Int. 2014. PMID: 24380911 No abstract available.